The impact of extrahepatic disease among patients undergoing liver‐directed therapy for neuroendocrine liver metastasis

Introduction Management of neuroendocrine liver metastasis (NELM) in the presence of extrahepatic disease (EHD) is controversial. We sought to examine outcomes of patients undergoing liver‐directed therapy (resection, ablation, or both) for NELM in the presence of EHD using a large international cohort of patients. Methods 612 patients who underwent liver‐directed therapy were identified from eight institutions. Postoperative outcomes, as well...